Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy, safety and tolerability of SYR-472,
once daily (QD), in subjects with Type 2 Diabetes Mellitus.